Back to top
more

Inspire Medical Systems (INSP)

(Delayed Data from NYSE)

$249.72 USD

249.72
354,939

-1.47 (-0.59%)

Updated May 3, 2024 04:00 PM ET

After-Market: $249.93 +0.21 (0.08%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value A Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (100 out of 252)

Industry: Medical Info Systems

Better trading starts here.

Zacks News

Will Low Patient Days Impact Community Health (CYH) Q1 Earnings?

Community Health's (CYH) first-quarter results are likely to reflect declining beds in services and adjusted admissions.

ICON (ICLR) Gains From New Offerings, Strategic Acquisitions

ICON (ICLR) continues to develop its collaboration and delivery models, invest in technology and enhance its project and program management capabilities.

CVS Health (CVS) to Report Q1 Earnings: What's in the Cards?

The strength of a diversified enterprise, along with robust operational execution, is expected to be reflected in CVS Health's (CVS) first-quarter 2024 results.

Inspire (INSP) Surges 9.9%: Is This an Indication of Further Gains?

Inspire (INSP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Abbott (ABT) Q1 Earnings Beat Estimates, Margins Contract

Abbott (ABT) delivers double-digit organic sales growth in its underlying base business in the first quarter of 2024.

Here's Why You Should Retain Henry Schein (HSIC) Stock for Now

Favorable Dental business trends and expansion efforts through acquisitions and partnerships bode well for Henry Schein (HSIC).

UnitedHealth Group (UNH) Tops on Q1 Earnings, Reaffirms EPS View

UnitedHealth Group (UNH) first-quarter earnings benefit from strong Optum and UnitedHealthcare business lines. Rising expenses partially offset the positives.

Labcorp (LH) to Report Q1 Earnings: What's in the Cards?

Labcorp (LH) is anticipated to drive growth in the first quarter of 2024 through base business expansion, integrating acquisitions and partnerships and advancing in science and technology.

Will Elevance (ELV) Beat Q1 Earnings on Carelon Strength?

The first-quarter results of Elevance (ELV) are likely to reflect higher product revenues and Commercial Individual membership growth.

Quest Diagnostics (DGX) to Post Q1 Earnings: What's in Store?

Acquisitions and partnerships with health plans are expected to drive Quest Diagnostics' (DGX) base business performance in the first quarter of 2024.

Can High Medical Costs Affect UnitedHealth's (UNH) Q1 Earnings?

UnitedHealth's (UNH) first-quarter results are likely to reflect growth in premium levels and service revenues.

Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

Will UnitedHealth's (UNH) UnitedHealthcare Unit Aid Q1 Earnings?

UnitedHealth's (UNH) first-quarter results are expected to benefit from an increase in UnitedHealthcare's Community & State revenues and the number of people it served.

New Strong Buy Stocks for April 9th

SRDX, X, TELNY, INSP and MTAL have been added to the Zacks Rank #1 (Strong Buy) List on April 9, 2023.

Urmimala Biswas headshot

3 Medical Info Systems Stocks to Buy as Industry Improves

A few Zacks Medical Info Systems industry stocks like Inspire Medical Systems (INSP), Talkspace (TALK) and Health Catalyst (HCAT) are expected to gain from the new normal trends.

Here's Why You Should Retain Inspire Medical (INSP) Stock Now

Inspire Medical's (INSP) focus on R&D raises optimism about the stock.

Brookdale Senior's (BKD) Q4 Loss Widens, Shares Drop 13%

Brookdale Senior's (BKD) Q4 results were hit by inflationary challenges, an increase in facility operating lease expense and higher income tax provision. It expects adjusted EBITDA within $90-$95 million in first-quarter 2024.

Encompass Health (EHC) Q4 Earnings Beat on Higher Discharges

Encompass Health's (EHC) Q4 results gain on improved net patient revenue per discharge and higher net income. Management estimates 2024 adjusted EPS to be $3.77-$4.06.

Inspire Medical (INSP) Q4 Earnings Top Estimates, Gross Margin Up

Inspire Medical's (INSP) U.S. region witnesses strong revenue growth in the fourth quarter.

Compared to Estimates, Inspire (INSP) Q4 Earnings: A Look at Key Metrics

The headline numbers for Inspire (INSP) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Inspire Medical Systems (INSP) Surpasses Q4 Earnings and Revenue Estimates

Inspire (INSP) delivered earnings and revenue surprises of 1,325% and 0.05%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Inspire Medical Systems (INSP) Expected to Beat Earnings Estimates: Should You Buy?

Inspire (INSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Inspire Medical (INSP) Reports Solid Preliminary Q4 Revenues

Inspire Medical's (INSP) revenue growth in the fourth quarter is likely to have been boosted by improved operating leverage.

3 Reasons to Hold Inspire Medical (INSP) Stock in Your Portfolio

Inspire Medical's (INSP) focus on R&D raises optimism about the stock.

Inspire (INSP) Up 16.8% Since Last Earnings Report: Can It Continue?

Inspire (INSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.